Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eton Pharmaceuticals, Inc.

16.97
-0.3700-2.13%
Post-market: 16.970.00000.00%19:37 EDT
Volume:253.38K
Turnover:4.32M
Market Cap:455.09M
PE:-114.95
High:17.34
Open:17.29
Low:16.73
Close:17.34
Loading ...

Eton Pharmaceuticals Price Target Raised to $24.00/Share From $21.00 by B. Riley Securities

Dow Jones
·
19 Mar

Eton Pharmaceuticals price target raised to $26 from $23 at Craig-Hallum

TIPRANKS
·
19 Mar

B. Riley Raises Price Target on Eton Pharmaceuticals to $24 From $21, Keeps Buy Rating

MT Newswires Live
·
19 Mar

Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
19 Mar

BUZZ-Eton Pharma falls after fourth-quarter loss

Reuters
·
19 Mar

Eton Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
18 Mar

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
18 Mar

Eton Pharmaceuticals Q4 2024 GAAP EPS $(0.02) Vs. $(0.09) YoY, Sales $11.65M Beat $10.53M Estimate

Benzinga
·
18 Mar

BRIEF-Eton Pharmaceuticals Q4 Net Income USD -598 Thousand

Reuters
·
18 Mar

Eton Pharmaceuticals Inc: Co Expects Sequential Growth in Qtrly Product Revenue to Continue Through 2025 and Beyond

THOMSON REUTERS
·
18 Mar

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

GlobeNewswire
·
18 Mar

Eton Pharmaceuticals (NASDAQ:ETON) shareholder returns have been incredible, earning 421% in 5 years

Simply Wall St.
·
17 Mar

Eton Pharmaceuticals Shares up 1.5% on Rare Disease Drug Data

THOMSON REUTERS
·
14 Mar

Eton Pharmaceuticals Inc expected to post breakeven results a share - Earnings Preview

Reuters
·
14 Mar

BUZZ-Eton Pharma rises on study results for rare disease drug

Reuters
·
14 Mar

Eton's Diabetes Drug Candidate Passes Bioequivalence Study

MT Newswires Live
·
14 Mar

Eton Pharmaceuticals reports ‘positive’ data from study of ET-600

TIPRANKS
·
14 Mar

Eton Pharmaceuticals Inc - Expects to Submit Nda for Et-600 in April 2025

THOMSON REUTERS
·
14 Mar

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate Et-600

THOMSON REUTERS
·
14 Mar

Eton Pharmaceuticals (ETON) Gets a Buy from Craig-Hallum

TIPRANKS
·
13 Mar